Heather Bresch
Chief Executive Officer chez Mylan Pharmaceuticals, Inc.
Profil
Heather M.
Bresch currently works at Mylan Pharmaceuticals, Inc., as Chief Executive Officer & Director and Viatris Healthcare (Pty) Ltd., as Chief Executive Officer.
Ms. Bresch also formerly worked at Mylan, Inc., as President, Chief Executive Officer & Director in 2012, Association for Accessible Medicines, as Chairman, Mylan Laboratories, Inc., as Head-North American Operations from 1992 to 2007, Mylan Technologies, Inc., as Head-North American Operations, Mylan NV, as President from 2009 to 2012, Mylan Laboratories Ltd., as Chief Integration Officer, and Mylan Institutional, Inc., as Head-North American Operations.
Ms. Bresch received her undergraduate degree and Masters Business Admin degree from West Virginia University.
Postes actifs de Heather Bresch
Sociétés | Poste | Début |
---|---|---|
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Chief Executive Officer | - |
Viatris Healthcare (Pty) Ltd.
Viatris Healthcare (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa. | Chief Executive Officer | - |
Anciens postes connus de Heather Bresch
Sociétés | Poste | Fin |
---|---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | 02/10/2007 |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Chairman | - |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Chief Executive Officer | - |
MYLAN LABORATORIES LTD | Corporate Officer/Principal | - |
Mylan Institutional, Inc.
Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Corporate Officer/Principal | - |
Formation de Heather Bresch
West Virginia University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 9 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Mylan Technologies, Inc. designs, develops, and manufactures transdermal drug delivery systems, and associated materials and technologies. The company is headquartered in St. Albans, VT. | Process Industries |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Mylan Laboratories Ltd.
Mylan Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India. | Health Technology |
Mylan Institutional, Inc.
Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Health Technology |
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Viatris Healthcare (Pty) Ltd.
Viatris Healthcare (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa. | Health Technology |